10.3389/fcimb.2024.1374544 55 YangY.WangY.ZhouY.DengJ.WuL
Key Takeaways Two biotech companies, Akston Biosciences and OKAVA Pharmaceuticals, are running early trials of once-weekly injections and a six-month implant GLP-1 treatment to tackle feline obesity, with no approved Ozempic for pets on the market yet
Insulin and some diabetes medications (e.g., sulfonylureas): May promote weight gain by increasing insulin levels, which can encourage fat storage
Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: a registry-based cohort study
Indian companies were issued 81 new CEPs in Q1 2026 (as against 40 in Q1 2025) and 203 revisions (as against 129 in Q1 2025)
Dietary modification, portion control, simethicone, and Pepto-Bismol resolve burping for the vast majority of semaglutide users without requiring a medication change